99 related articles for article (PubMed ID: 31685801)
41. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
Liu L; Wong CC; Gong B; Yu J
Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
[TBL] [Abstract][Full Text] [Related]
42. Expression Analysis of RbBP6 in human cancers: a Prospective biomarker.
Mbita Z; Hull R; Mbele M; Makhafola T; Dlamini Z
Anticancer Drugs; 2019 Sep; 30(8):767-773. PubMed ID: 31274515
[TBL] [Abstract][Full Text] [Related]
43. RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial-mesenchymal transition and promotes metastasis of colorectal cancer.
Xiao C; Wu G; Zhou Z; Zhang X; Wang Y; Song G; Ding E; Sun X; Zhong L; Li S; Weng J; Zhu Z; Chen J; Wang X
Cell Death Dis; 2019 Nov; 10(11):833. PubMed ID: 31685801
[TBL] [Abstract][Full Text] [Related]
44. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
Wang J; Zhao X; Jin L; Wu G; Yang Y
Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
[TBL] [Abstract][Full Text] [Related]
45. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.
Xin H; Wang C; Liu Z
BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631
[TBL] [Abstract][Full Text] [Related]
46. RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway via Ubiquitination of TLE3.
Liu L; Zhang Y; Wong CC; Zhang J; Dong Y; Li X; Kang W; Chan FKL; Sung JJY; Yu J
Cancer Res; 2018 Apr; 78(8):1958-1971. PubMed ID: 29374067
[TBL] [Abstract][Full Text] [Related]
47. Ubiquitin ligase TRIM65 promotes colorectal cancer metastasis by targeting ARHGAP35 for protein degradation.
Chen D; Li Y; Zhang X; Wu H; Wang Q; Cai J; Cui Y; Liu H; Lan P; Wang J; Yang Z; Wang L
Oncogene; 2019 Sep; 38(37):6429-6444. PubMed ID: 31332286
[TBL] [Abstract][Full Text] [Related]
48. Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy.
Shen T; Cai LD; Liu YH; Li S; Gan WJ; Li XM; Wang JR; Guo PD; Zhou Q; Lu XX; Sun LN; Li JM
J Hematol Oncol; 2018 Jul; 11(1):95. PubMed ID: 30016968
[TBL] [Abstract][Full Text] [Related]
49. Cancer statistics, 2019.
Siegel RL; Miller KD; Jemal A
CA Cancer J Clin; 2019 Jan; 69(1):7-34. PubMed ID: 30620402
[TBL] [Abstract][Full Text] [Related]
50. Colorectal cancer statistics, 2017.
Siegel RL; Miller KD; Fedewa SA; Ahnen DJ; Meester RGS; Barzi A; Jemal A
CA Cancer J Clin; 2017 May; 67(3):177-193. PubMed ID: 28248415
[TBL] [Abstract][Full Text] [Related]
51. Emerging Biological Principles of Metastasis.
Lambert AW; Pattabiraman DR; Weinberg RA
Cell; 2017 Feb; 168(4):670-691. PubMed ID: 28187288
[TBL] [Abstract][Full Text] [Related]
52. RBBP6: a potential biomarker of apoptosis induction in human cervical cancer cell lines.
Moela P; Motadi LR
Onco Targets Ther; 2016; 9():4721-35. PubMed ID: 27536134
[TBL] [Abstract][Full Text] [Related]
53. EMT: 2016.
Nieto MA; Huang RY; Jackson RA; Thiery JP
Cell; 2016 Jun; 166(1):21-45. PubMed ID: 27368099
[TBL] [Abstract][Full Text] [Related]
54. Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database.
Shah MA; Renfro LA; Allegra CJ; André T; de Gramont A; Schmoll HJ; Haller DG; Alberts SR; Yothers G; Sargent DJ
J Clin Oncol; 2016 Mar; 34(8):843-53. PubMed ID: 26811529
[TBL] [Abstract][Full Text] [Related]
55. Inflammatory stimuli promote growth and invasion of pancreatic cancer cells through NF-κB pathway dependent repression of PP2Ac.
Tao M; Liu L; Shen M; Zhi Q; Gong FR; Zhou BP; Wu Y; Liu H; Chen K; Shen B; Wu MY; Shou LM; Li W
Cell Cycle; 2016; 15(3):381-93. PubMed ID: 26761431
[TBL] [Abstract][Full Text] [Related]
56. Population-based programs for increasing colorectal cancer screening in the United States.
Verma M; Sarfaty M; Brooks D; Wender RC
CA Cancer J Clin; 2015; 65(6):497-510. PubMed ID: 26331705
[TBL] [Abstract][Full Text] [Related]
57. Global loss of DNA methylation uncovers intronic enhancers in genes showing expression changes.
Blattler A; Yao L; Witt H; Guo Y; Nicolet CM; Berman BP; Farnham PJ
Genome Biol; 2014 Sep; 15(9):469. PubMed ID: 25239471
[TBL] [Abstract][Full Text] [Related]
58. Oncogenic roles of EMT-inducing transcription factors.
Puisieux A; Brabletz T; Caramel J
Nat Cell Biol; 2014 Jun; 16(6):488-94. PubMed ID: 24875735
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
